title: Tetrabenazine for involuntary movement disorders.
abstract: The use of tetrabenazine to treat the movement disorder of Huntington's chorea and other dyskinesias is described. Tetrabenazine produced moderate to marked improvement in the movement disorder in 79% of a series of 40 Australian patients. The most commonly reported side effects were depression, drowsiness and Parkinsonism.
mesh_terms: D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D013747:Tetrabenazine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D013747:Tetrabenazine